Omega Diagnostics Group PLC (LSE:ODX) - Share price


Stock Report

Omega Diagnostics Group PLC ODX

Last Price
GBX12.88

Day Change
-0.38|-2.83%

As of 21/01/2022
17:06:50 GMT | GBX
Minimum 15 Minutes Delay.

Last Close13.25p
Day Range12.55 - 13.33
Mkt Cap23.52Mil
52-Wk Range12.55 - 117.98
Yield %-
ISINGB00B1VCP282
Volume3,538,627
P/E-
P/S0.03
P/CF-0.09

Share Price

Total Returns 21/01/2022

 Chg (%)  
More ...
Omega Diagnostics Group PLC-37.20 
FTSE 100 TR GBP2.82
 
Financials
201920202021
More ...
Income Statement
Turnover8.769.828.74
Operating Profit-0.270.70-3.32
Net Profit-0.34-6.83-2.10
Reported EPS-0.30-4.84-1.20
Balance Sheet
Current Assets3.494.4612.24
Non Current Assets19.9914.3818.75
Total Assets23.4818.8430.99
Current Liabilities2.312.343.55
Total Liabilities5.295.237.32
Total Equity18.1913.6123.67
Cash Flow
Operating Cash Flow0.250.38-2.56
Net Change in Cash0.010.035.83
Director Dealings
TradedActionNotifierPriceAmountValue
More ...
09/04/2021Exercise of OptionMr. William E. Rhodes III15.25300,00045,750.00
09/04/2021Sale of OptionMr. William E. Rhodes III79.31300,000237,926.00
25/02/2021Exercise of OptionMr. William E. Rhodes III15.25450,00068,625.00
25/02/2021Sale of OptionMr. William E. Rhodes III91.12450,000410,018.00

Company Profile

Omega Diagnostics Group PLC provides in-vitro diagnostics (IVD) products for use in hospitals, blood banks, clinics and laboratories and specializes in the areas of allergy and autoimmune, food intolerance and infectious diseases. The company's segment includes Health and Nutrition; Global Health and Other. It generates maximum revenue from the Health and Nutrition segment. The Health and Nutrition division specialises in the research, development, and production of kits to aid the detection of immune reactions to food. Geographically, it derives a majority of revenue from Asia and the Far East region.

Sector

Medical Instruments & Supplies

Index

FTSE AIM All-Share

Next Event 13/07/2022

Final Results
Ratios
Comp
More ...
PER (E)0.00
Div Yld (E)0.00
PEG (E)0.00
ROCE-12.11
Op Mrgn-0.38
EPS Grwth0.00
Dividends
PreviousLatest
More ...
Record Datet.b.c.t.b.c.
Ex-Divt.b.c.t.b.c.
Paidt.b.c.t.b.c.
Amnt0.000.00
Directors
More ...
Executive Director, Chief Executive OfficerMr. Jagdeep Grewal
Non-Executive DirectorMr. William E. Rhodes III
Non-Executive DirectorMr. Jeremy Howard Millard
Non-Executive Director, ChairmanDr. Simon Gordon Douglas
AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2022 Morningstar. All rights reserved.